Kapios Health Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 3

Kapios Health General Information

Description

Provider of mobile application development, infrastructure and commercialization services intended for healthcare providers. The company's Assured Compliance Solution replaces all cumbersome papers and notebooks with one tablet to boost the productivity of lab engineers and technicians and its IOSurge Solution ensures the appropriate billing code and patient status is correctly communicated between physician offices and hospitals, enabling healthcare practitioners to provide exemplary patient care supported by sophisticated industry-inspired, field-tested, technology support.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Medical Records Systems
Primary Office
  • 2865 North Reynolds Road
  • Suite 220D
  • Toledo, OH 43615
  • United States
+1 (567) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kapios Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
1. Joint Venture 04-Oct-2016 Completed Generating Revenue
To view Kapios Health’s complete valuation and funding history, request access »

Kapios Health Executive Team (1)

Name Title Board Seat Contact Info
Justin Hammerling Chief Executive Officer
To view Kapios Health’s complete executive team members history, request access »

Kapios Health Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ProMedica Innovations Accelerator/Incubator 000 0000 000000 0
Kaonsoft Corporation Majority 000 0000 000000 0
ProMedica Corporation Majority 000 0000 000000 0
To view Kapios Health’s complete investors history, request access »